Jerold Chun Selected Research

Fatigue

1/2022

Ponesimod inhibits astrocyte-mediated neuroinflammation and protects against cingulum demyelination via S1P1 -selective modulation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jerold Chun Research Topics

Disease

26	Multiple Sclerosis 12/2023 - 01/2006
16	Fibrosis (Cirrhosis) 01/2023 - 01/2007
16	Inflammation (Inflammations) 01/2023 - 04/2008
14	Neuralgia (Stump Neuralgia) 01/2022 - 07/2004
11	Aneuploidy (Aneuploid) 01/2021 - 11/2003
9	Neoplasms (Cancer) 01/2015 - 04/2004
8	Demyelinating Diseases (Demyelinating Disease) 01/2022 - 07/2004
7	Alzheimer Disease (Alzheimer's Disease) 04/2024 - 02/2015
7	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 12/2023 - 02/2011
6	Pain (Aches) 01/2022 - 08/2006
5	Lung Injury 01/2023 - 01/2008
5	Myocardial Ischemia (Ischemic Heart Diseases) 01/2017 - 09/2006
5	Reperfusion Injury 01/2016 - 09/2006
4	Hyperalgesia 12/2018 - 07/2004
4	Atherosclerosis 01/2017 - 08/2008
4	Pulmonary Fibrosis (Fibrosing Alveolitis) 12/2013 - 01/2008
3	Pathologic Processes 05/2024 - 12/2002
3	Neuroinflammatory Diseases 12/2023 - 04/2021
3	Sepsis (Septicemia) 01/2023 - 04/2008
3	Hemorrhage 01/2023 - 09/2011
3	Brain Diseases (Brain Disorder) 10/2022 - 01/2021
3	Body Weight (Weight, Body) 01/2022 - 03/2009
3	Spinal Cord Injuries (Spinal Cord Injury) 01/2022 - 07/2015
3	Down Syndrome (Down's Syndrome) 11/2021 - 02/2015
3	Carcinogenesis 01/2018 - 05/2009
3	Infarction (Infarctions) 01/2017 - 09/2006
3	Hypertrophy 01/2017 - 01/2016
3	Hypoxia (Hypoxemia) 01/2012 - 11/2010
2	Thrombosis (Thrombus) 01/2022 - 11/2019
2	Chronic Progressive Multiple Sclerosis 01/2022 - 01/2022
2	Atrophy 01/2022 - 06/2009
2	Wounds and Injuries (Trauma) 01/2022 - 05/2013
2	Arthritis (Polyarthritis) 01/2022 - 08/2013
2	Ischemic Stroke 01/2021 - 01/2015
2	Ischemia 01/2017 - 02/2007
2	Ureteral Obstruction 01/2017 - 12/2007
2	Bone Resorption 10/2014 - 03/2014
2	Idiopathic Pulmonary Fibrosis 12/2013 - 01/2008
2	Asthma (Bronchial Asthma) 10/2013 - 11/2009
2	Pneumonia (Pneumonitis) 10/2013 - 10/2011
2	Cardiovascular Diseases (Cardiovascular Disease) 05/2011 - 01/2010
2	Autoimmune Diseases of the Nervous System 03/2010 - 08/2004
2	Peripheral Nerve Injuries 08/2006 - 07/2004
2	Ovarian Neoplasms (Ovarian Cancer) 03/2005 - 02/2004
2	Neuroblastoma 06/2002 - 04/2002
1	Common Cold 03/2024
1	Neurologic Manifestations (Neurological Manifestations) 12/2023

Drug/Important Bio-Agent (IBA)

40	Lysophosphatidic Acid ReceptorsIBA 01/2022 - 07/2004
35	lysophosphatidic acidIBA 01/2022 - 06/2002
28	Sphingosine-1-Phosphate ReceptorsIBA 01/2023 - 04/2004
20	Fingolimod Hydrochloride (FTY720)FDA Link 12/2023 - 08/2004
15	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 12/2022 - 09/2006
14	Proteins (Proteins, Gene)FDA Link 01/2023 - 09/2004
13	LipidsIBA 01/2022 - 12/2002
6	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 01/2008
5	CytokinesIBA 05/2024 - 06/2005
5	Amyloid (Amyloid Fibrils)IBA 01/2020 - 02/2015
5	Bleomycin (Blenoxane)FDA LinkGeneric 12/2013 - 01/2008
5	LysophospholipidsIBA 07/2011 - 06/2002
4	Phospholipids (Phosphatides)FDA LinkGeneric 10/2011 - 04/2004
3	SphingolipidsIBA 12/2022 - 09/2006
3	siponimodIBA 01/2022 - 02/2021
3	CollagenIBA 01/2022 - 05/2013
3	RNA (Ribonucleic Acid)IBA 01/2022 - 11/2021
3	NucleotidesIBA 01/2021 - 11/2003
3	EnzymesIBA 12/2018 - 02/2008
3	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2017 - 09/2011
3	alkylglycerophosphoethanolamine phosphodiesteraseIBA 01/2012 - 04/2004
3	3- (4- (4- ((1- (2- chlorophenyl)ethoxy)carbonyl amino)-3-methyl-5-isoxazolyl) benzylsulfanyl) propanoic acidIBA 10/2011 - 04/2004
3	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 11/2010 - 04/2004
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2007 - 05/2004
2	Messenger RNA (mRNA)IBA 04/2024 - 01/2017
2	Coloring Agents (Dyes)IBA 01/2023 - 01/2008
2	LipopolysaccharidesIBA 01/2023 - 10/2011
2	Biomarkers (Surrogate Marker)IBA 10/2022 - 02/2021
2	ponesimodIBA 01/2022 - 02/2021
2	Protein Isoforms (Isoforms)IBA 11/2021 - 07/2004
2	Fatty Acids (Saturated Fatty Acids)IBA 04/2021 - 10/2013
2	Retroelements (Retrotransposon)IBA 01/2021 - 04/2013
2	sphingosine kinaseIBA 11/2019 - 02/2010
2	oxidized low density lipoproteinIBA 01/2017 - 05/2011
2	Complement System Proteins (Complement)IBA 04/2013 - 04/2008
2	Myelin-Associated GlycoproteinIBA 11/2010 - 05/2010
2	Myelin ProteinsIBA 05/2010 - 08/2004
2	GTP-Binding Proteins (G-Protein)IBA 02/2010 - 11/2009
2	HDL LipoproteinsIBA 08/2008 - 09/2006
2	Transforming Growth Factor beta (TGF-beta)IBA 12/2007 - 01/2007
1	Reverse Transcriptase InhibitorsIBA 03/2024
1	NucleosidesIBA 03/2024
1	DNA-Directed RNA Polymerases (RNA Polymerase)IBA 03/2024
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 12/2023
1	Transcobalamins (Transcobalamin II)IBA 12/2023
1	VitaminsIBA 12/2023
1	cadherin 5IBA 01/2023
1	Evans Blue (Blue, Evans)FDA Link 01/2023

Therapy/Procedure

17	Therapeutics 03/2024 - 04/2004
3	Ligation 01/2020 - 05/2012
3	Spinal Injections 06/2013 - 11/2009
2	Transplantation 01/2011 - 01/2007
2	Kidney Transplantation 02/2006 - 01/2006